Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

109 recalls, newest first

Class II · Moderate risk

Norepinephrine Bitartrate in 5% Dextrose Injection

Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.

Ongoing Labeling / mix-up Baxter Healthcare Corporation D-0336-2024
Class II · Moderate risk

Medline Remedy Clinical TREAT Antifungal Cream

Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list.

Ongoing Labeling / mix-up MEDLINE INDUSTRIES, LP - Northfield D-0315-2024
Class II · Moderate risk

Nystatin 150 Mu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-1 D-0157-2024
Class II · Moderate risk

Nystatin 2 Bu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-4 D-0156-2024
Class II · Moderate risk

Nystatin 500 Mu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-3 D-0155-2024
Class II · Moderate risk

Nystatin 5bu

Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Ongoing Labeling / mix-up Fagron, Inc NDC 51552-0041-5 D-0154-2024
Class III · Low risk

Tropicamide 1%

Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper

Ongoing Labeling / mix-up Fagron Compounding Services NDC 71266-8240-01 D-0125-2024
Class II · Moderate risk

Naproxen Tablets

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Ongoing Labeling / mix-up Glenmark Pharmaceuticals Inc., USA NDC 68462-188-01 D-0124-2024
Class II · Moderate risk

Indomethacin 25mg Capsules

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Ongoing Labeling / mix-up Glenmark Pharmaceuticals Inc., USA NDC 68462-406-01 D-0123-2024
Class III · Low risk

Synthroid

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

Ongoing Labeling / mix-up AbbVie Inc. NDC 0074-7068-11 D-0088-2024
Class III · Low risk

Lidocaine Patch 5%

Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. D-0556-2023
Class III · Low risk

MEKTOVI (binimetinib)

Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

Ongoing Labeling / mix-up Pfizer Inc. D-0532-2023
Class II · Moderate risk

The Natural Dentist Healthy Balance Peppermint Sage

Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC 7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8

Ongoing Labeling / mix-up Revive Personal Products Company D-0364-2022
Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0257-2022
Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0256-2022
Class I · High risk

Limar Hand Sanitizer

Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.

Ongoing Labeling / mix-up Ardil Comercial S.R.L. D-0691-2021
Class III · Low risk

Distributed by: DocRx

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Ongoing Labeling / mix-up Asclemed USA Inc. dba Enovachem Pharmaceuticals D-0330-2021
Class I · High risk

Enoxaparin Sodium Injection

Labeling; Label Mixup; syringe barrels may contain markings for 100 mg/mL (corresponding to 100 mg/mL strength) instead of 150 mg/mL (corresponding to 120 mg/0.8mL strength)

Ongoing Labeling / mix-up Apotex Corp. NDC 60505-0796-4 D-0262-2021

Recalls by year